Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Columbia University
University of Nebraska
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
University of California, Davis
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
University of Arizona
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Stanford University
Stanford University
Children's Oncology Group
Fred Hutchinson Cancer Center
Children's Oncology Group
M.D. Anderson Cancer Center